Bli medlem
Bli medlem

Du är här

2021-10-28

Terveystalo Oyj: Terveystalo optimizes its capital structure by launching a share buyback program

Terveystalo Plc Stock Exchange Release, 28 Oct 2021 at 08:57 EEST

The Board of Directors of Terveystalo Plc has today, 28 October, 2021, decided to launch a buyback program for Terveystalo's own shares based on the authorisation granted by Terveystalo's Annual General Meeting on 25 March 2021.

The purpose of the share buyback program is to optimize the Company's capital structure through reduction of capital. The repurchase of own shares will reduce the Company's unrestricted equity. The repurchased shares will be cancelled.

The aggregate purchase price of all Terveystalo shares to be acquired under the buyback program shall not exceed EUR 13,5 million. The maximum amount of Terveystalo shares that can be repurchased in the buyback program is 1,000,000 shares corresponding to approximately 0.8 per cent of the total number of shares in Terveystalo.

The share repurchases will start at the earliest on 29 October 2021 and end by 6 April 2022.

The repurchases will be carried out in accordance with the so-called safe harbour procedure referred to in Article 5 of the EU Market Abuse Regulation (EU N:o 596/2014). The shares will be acquired through public trading on Nasdaq Helsinki. Terveystalo has appointed Nordea as the manager for the share buyback program. The manager will make trading decisions independently of and without influence from Terveystalo, within the announced limits. This concerns also the timing of purchases.

The price payable per share shall be determined in public trading on Nasdaq Helsinki at the time of the repurchases, in compliance with the price and volume limits applicable under the safe harbor procedure. The minimum price to be paid would be the lowest market price of the share quoted during the authorisation period and the maximum price would be the highest market price quoted during the authorisation period.

Terveystalo may suspend or terminate the program prior to its scheduled end date and will in such case issue a stock exchange release to this effect.

Terveystalo holds 730,000 own shares prior to the commencement of the buyback program.

For more information, please contact:
Liisa-Maija Seppänen, Investor Relations Manager
+358 50 3144 455
liisa-maija.seppanen@terveystalo.com

Distribution:
Nasdaq Helsinki Oy
Principal media
www.terveystalo.com

Författare Cision